RareX enters financial year 2027 with strategy
RareX (ASX:REE) has entered financial year 2027 with an updated strategy focused on diversified critical mineral assets.
RareX (ASX:REE) has entered financial year 2027 with an updated strategy focused on diversified critical mineral assets.
The Australian unemployment rate remained steady at 4.4% in June following a 76,000 person surge in total employment.
Bayan Mining and Minerals (ASX:BMM) executed an agreement to divest its Bayan Springs North asset to Sun Silver (ASX:SS1).
Clinuvel Pharmaceuticals (ASX:CUV) will relocate its corporate headquarters to the U.S. by Jan. 1, 2027 and reduce its global workforce by 10% to 20%.
Dimerix (ASX:DXB) secured a United States patent for its drug candidate DMX-652 through 2043.
While Alphabet showed booming Cloud revenue to justify its surging AI spending, Tesla asked investors for patience as its massive capital expenditure builds toward unproven long shots like robotaxis and robotics. Bloomberg's Ed Ludlow reports.
Medical technology company PolyNovo (ASX:PNV) reported a 16.1% rise in annual group revenue to $150 million for FY26.
Karoon Energy (ASX:KAR) recorded second-quarter sales revenue of US$116.4 million after producing 1.08 million barrels of oil equivalent
Pureprofile (ASX:PPL) reported full-year revenue of $65 million for FY26, representing a 14% year-on-year increase.
Credit Clear (ASX:CCR) reported a 28% revenue increase to $60 million for the financial year ended June 30.
Sandfire Resources (ASX:SFR) generated quarterly sales revenue of $574 million following a 38% increase in copper equivalent production.
James Hardie (ASX:JHX) raised its first-quarter revenue outlook to between US$1.45 billion and US$1.48 billion.